The prognostic value of IKZF1<sup>plus</sup> in B-cell progenitor acute lymphoblastic leukemia: Results from the EORTC 58951 trial.

导出原文传递

翻译打印收藏纠错

第一作者： Michal,Kicinski

第一单位： EORTC Headquarters, Brussels, Belgium.

作者： Michal,Kicinski ^[1] ; Chloé,Arfeuille ^[2] ; Nathalie,Grardel ^[3] ; Marleen,Bakkus ^[4] ; Aurélie,Caye-Eude ^[2] ; Geneviève,Plat ^[5] ; Alina,Ferster ^[6] ; Anne,Uyttebroeck ^[7] ; Barbara,De Moerloose ^[8] ; Pierre,Rohrlich ^[9] ; Stefan,Suciu ^[1] ; Yves,Bertrand ^[10] ; Hélène,Cavé ^[2]

作者单位： EORTC Headquarters, Brussels, Belgium. ^[1] Département de Génétique, Hôpital Robert Debré, Assistance Publique des Hôpitaux de Paris (AP-HP), Paris, France.;INSERM, UMR_S1131, Institut de Recherche Saint-Louis, Université Paris-Cité, Paris, France. ^[2] Haematology laboratory, CHU Lille, Lille, France. ^[3] Laboratory of Molecular Haematology, University Hospital Brussels, Vrije Universiteit Brussel (VUB), Brussels, Belgium. ^[4] Department of Hematology, CHU Toulouse, Toulouse, France. ^[5] Department of Hemato-Oncology, HUDERF (ULB), Brussels, Belgium. ^[6] Department of Pediatric Hemato-Oncology, University Hospital Leuven, Leuven, Belgium. ^[7] Department of Pediatric Hematology-Oncology, Ghent University Hospital, Ghent, Belgium. ^[8] Department of Pediatric Oncology, CHU Nice, Nice, France. ^[9] Institut d'Hématologie et d'Oncologie Pédiatrique, Hospices Civils de Lyon, Université Lyon, Lyon, France. ^[10]

关键词 B-cell precursor acute lymphoblastic leukemia IKZF1 MLPA prognostic